Alpha 2.0
Login Register
» Articles » PMID: 11055609

Bacteriologic Outcome of Children with Cefotaxime- or Ceftriaxone-susceptible and -nonsusceptible Streptococcus Pneumoniae Meningitis

Overview
Journal Pediatr Infect Dis J
Specialty Pediatrics
Date 2000 Oct 31
PMID 11055609
Citations 7
Authors
C Olivier
R Cohen
P Begue
D Floret
Affiliations
Soon will be listed here.
Citing Articles

Fosfomycin-Containing Regimens for the Treatment of Central Nervous System Infections in a Neonatal Intensive Care Unit: A Case Series Study.

Lenzi A, Saccani B, Di Gregorio M, Rossini F, Sollima A, Mule A Antibiotics (Basel). 2024; 13(7).

PMID: 39061349 PMC: 11273375. DOI: 10.3390/antibiotics13070667.

Fosfomycin in the pediatric setting: Evidence and potential indications.

Baquero-Artigao F, Del Rosal Rabes T Rev Esp Quimioter. 2019; 32 Suppl 1:55-61.

PMID: 31131593 PMC: 6555161.

Clinical implication of extended-spectrum cephalosporin nonsusceptibility in Streptococcus pneumoniae meningitis.

Chung J, Kim B, Kwak Y, Kim T, Lee E, Choo E Eur J Clin Microbiol Infect Dis. 2012; 31(11):3029-34.

PMID: 22661125 DOI: 10.1007/s10096-012-1657-z.

Pneumococcal meningitis in the era of pneumococcal conjugate vaccine implementation.

Bingen E, Levy C, Varon E, de La Rocque F, Boucherat M, dAthis P Eur J Clin Microbiol Infect Dis. 2007; 27(3):191-9.

PMID: 18060439 DOI: 10.1007/s10096-007-0417-y.

Setting and revising antibacterial susceptibility breakpoints.

Turnidge J, Paterson D Clin Microbiol Rev. 2007; 20(3):391-408, table of contents.

PMID: 17630331 PMC: 1932754. DOI: 10.1128/CMR.00047-06.